Close

Johnson & Johnson (JNJ) Announces FDA Approval of Invega Trinza as Schizophrenia Treatment

May 19, 2015 8:04 AM EDT Send to a Friend
There's a new treatment option for schizophrenia – INVEGA TRINZA (three-month paliperidone palmitate), the first and only schizophrenia medication to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login